Contrasting Roles of the IL-1 and IL-18 Receptors in MyD88-Dependent Contact Hypersensitivity

被引:36
作者
Klekotka, Paul A. [2 ]
Yang, Liping
Yokoyama, Wayne M. [1 ]
机构
[1] Washington Univ, Dept Med, Med Ctr, Rheumatol Div,Howard Hughes Med Inst,Sch Med, St Louis, MO 63110 USA
[2] Dept Med, Div Dermatol, St Louis, MO USA
基金
美国国家卫生研究院;
关键词
TOLL-LIKE RECEPTOR; LANGERHANS CELL-MIGRATION; DERMAL DENDRITIC CELLS; NECROSIS-FACTOR-ALPHA; T-CELLS; IN-VIVO; ACTIVATION; INTERLEUKIN-1; KERATINOCYTES; EXPRESSION;
D O I
10.1038/jid.2009.242
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Contact hypersensitivity (CHS) requires activation of the innate immune system, and results in an adaptive immune response. Many cells of the innate immune system use Toll-like receptors (TLRs), which signal through the adaptor protein, MyD88, to initiate an immune response. MyD88 is also required for signaling downstream of the IL-1 and Il-18 receptors (IL-1R and IL-18R, respectively). Herein, we studied the MyD88 signaling pathway in the CHS response to DNFB. Mice deficient in MyD88 were unable to mount a CHS response to DNFB. In contrast, mice deficient in Toll/IL-1R-containing adaptor-inducing IFN-beta, TLR2, TLR4, TLR6, and TLR9 had no defect in their ability to respond to DNFB. Although both IL-1R and IL-18R-deficient mice showed a reduced CHS response to DNFB, in bone marrow chimera and adoptive transfer experiments, we found that MyD88 and the IL-18R were required in a radioresistant cell in the sensitization phase of the CHS response. In contrast, similar strategies revealed that the IL-1R was required in a radiosensitive cell in the sensitization phase of the CHS response. Taken together, these data indicate that the IL-1R and IL-18R/MyD88 pathways are required in distinctly different cells during the sensitization phase of CHS.
引用
收藏
页码:184 / 191
页数:8
相关论文
共 49 条
[31]  
Neumann D, 2002, EUR J IMMUNOL, V32, P3689, DOI 10.1002/1521-4141(200212)32:12<3689::AID-IMMU3689>3.0.CO
[32]  
2-X
[33]  
Okamoto I, 1999, J IMMUNOL, V162, P3202
[34]   Myeloid differentiation factor 88 is required for cross-priming in vivo [J].
Palliser, D ;
Ploegh, H ;
Boes, M .
JOURNAL OF IMMUNOLOGY, 2004, 172 (06) :3415-3421
[35]   Phosphatidylinositol 3-kinase in interleukin 1 signaling - Physical interaction with the interleukin 1 receptor and requirement in NF kappa B and AP-1 activation [J].
Reddy, SAG ;
Huang, JH ;
Liao, WSL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (46) :29167-29173
[36]   LANGERHANS CELL PRODUCTION OF INTERLEUKIN-1 [J].
SAUDER, DN ;
DINARELLO, CA ;
MORHENN, VB .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1984, 82 (06) :605-607
[37]   Toll-like receptors control activation of adaptive immune responses [J].
Schnare, M ;
Barton, GM ;
Holt, AC ;
Takeda, K ;
Akira, S ;
Medzhitov, R .
NATURE IMMUNOLOGY, 2001, 2 (10) :947-950
[38]   Epidermal and dermal dendritic cells display differential activation and migratory behavior while sharing the ability to stimulate CD4+ T cell proliferation in vivo [J].
Shklovskaya, Elena ;
Roediger, Ben ;
Fazekas de St Groth, Barbara .
JOURNAL OF IMMUNOLOGY, 2008, 181 (01) :418-430
[39]   Mice deficient in IL-1 beta manifest impaired contact hypersensitivity to trinitrochlorobenzene [J].
Shornick, LP ;
DeTogni, P ;
Mariathasan, S ;
Goellner, J ;
StraussSchoenberger, J ;
Karr, RW ;
Ferguson, TA ;
Chaplin, DD .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (04) :1427-1436
[40]   CDNA EXPRESSION CLONING OF THE IL-1 RECEPTOR, A MEMBER OF THE IMMUNOGLOBULIN SUPERFAMILY [J].
SIMS, JE ;
MARCH, CJ ;
COSMAN, D ;
WIDMER, MB ;
MACDONALD, HR ;
MCMAHAN, CJ ;
GRUBIN, CE ;
WIGNALL, JM ;
JACKSON, JL ;
CALL, SM ;
FRIEND, D ;
ALPERT, AR ;
GILLIS, S ;
URDAL, DL ;
DOWER, SK .
SCIENCE, 1988, 241 (4865) :585-589